Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Hemocompatibility related complications in impella 5+ patients treated with bivalirudine and dual antiplatelet therapy

Event: ESC Acute CardioVascular Care 2025

Topic: Nonpharmacological Treatment

Session: Predicting, assessing and managing cardiogenic shock

Access
Like
Thumbnail

Clinical outcomes of axillary-implanted impella 5.0/5.5 for ischemic cardiogenic shock: a retrospective single-center cohort study

Event: ESC Acute CardioVascular Care 2025

Topic: Cardiogenic Shock

Session: Cardiogenic shock unplugged: from risk stratification to rescue with mechanical circulatory support

Access
Like
Thumbnail

Central venous oxygen saturation as an early marker of systemic inflammatory response syndrome and predictor of outcome in cardiogenic shock

Event: ESC Acute CardioVascular Care 2025

Topic: Cardiogenic Shock

Session: Poster session 1

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources